Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
472 studies found for:    Open Studies | "neurological disorders"OR"brain tumors"OR"attention-deficit/hyperactivity disorder"OR"epilepsy"OR"chronic pain"OR"spincal cord injury"OR"stroke" | United States | Phase 1, 2, 3, 0 | Industry
Show Display Options
Rank Status Study
21 Recruiting Targeted Electrotherapy for Aphasia Stroke Rehabilitation (TEASER) - Phase II Multi-Center Study
Condition: Chronic Aphasia
Interventions: Device: HD-tDCS (Soterix Medical, Active);   Device: HD-tDCS (Soterix Medical, Sham)
22 Recruiting Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation
Conditions: Transient Ischemic Attack;   Stroke;   Atrial Fibrillation
Interventions: Drug: Apixaban;   Drug: Warfarin
23 Recruiting A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)
Condition: Cancer of Brain and Nervous System
Intervention: Device: bevacizumab, NovoTTF100A, temozolomide
24 Not yet recruiting Diffuse Optical Monitoring With Inhaled Nitric Oxide
Condition: Stroke
Intervention: Drug: Nitric Oxide
25 Recruiting Nivolumab With DC Vaccines for Recurrent Brain Tumors
Conditions: Malignant Glioma;   Astrocytoma;   Glioblastoma
Interventions: Drug: nivolumab;   Biological: DC
26 Recruiting Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
Condition: Partial Epilepsy
Intervention: Drug: YKP3089
27 Not yet recruiting ASIS for Botox in Upper Limb Spasticity
Conditions: Upper Limb Spasticity Unilaterally in Adults With History of Stroke;   Increased Muscle Tone in Elbow, Wrist, Finger, and Thumb Flexors.
Interventions: Drug: Gadolinium;   Drug: Efficacy of Botox intramuscularly at Week 6;   Drug: Efficacy of Botox intramuscularly at Week 12,;   Drug: Efficacy of Botox intramuscularly at Week 18;   Drug: Efficacy of Botox intramuscularly at Week 24;   Drug: Efficacy of Botox intramuscularly at Week 30;   Drug: Efficacy of Botox subdermally at Week 6;   Drug: Efficacy of Botox subdermally at Week 12;   Drug: Efficacy of Botox subdermally at Week 18;   Drug: Efficacy of Botox subdermally at Week 24;   Drug: Efficacy of Botox subdermally at Week 30;   Drug: Adverse Reactions of Botox intramuscularly;   Drug: Adverse Reactions of Botox subdermally
28 Recruiting Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into Patients With Multiple Sclerosis
Conditions: Multiple Sclerosis;   Autoimmune Diseases;   Autoimmune Diseases of the Nervous System;   Nervous System Diseases
Intervention: Procedure: Harvesting and Implantation of SVF
29 Recruiting Phase I Study of Safety and Immunogenicity of ADU-623
Conditions: Astrocytic Tumors;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Brain Tumor
Interventions: Biological: Cohort 1;   Biological: Cohort 2;   Biological: Cohort 3;   Drug: Antibiotics
30 Recruiting Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma
Conditions: Lymphoma;   Neuroblastoma;   Brain Tumor;   Solid Tumor
Intervention: Drug: CUDC-907
31 Recruiting Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases
Conditions: Breast Cancer;   Brain Tumor - Metastatic
Interventions: Drug: Cabozantinib;   Drug: Trastuzumab
32 Recruiting Repeat Dose Safety Study of NRL-1 in Epilepsy Subjects
Conditions: Acute Repetitive Seizures;   Breakthrough Seizures
Intervention: Drug: NRL-1
33 Recruiting Pharmacodynamic Study of Pembrolizumab in Patients With Recurrent Glioblastoma
Conditions: Brain Tumor;   Glioblastoma;   Cancer
Interventions: Drug: Pembrolizumab;   Procedure: Surgery
34 Recruiting Topotecan in Glioma Undergoing A Clinically-Indicated Surgical Resection
Conditions: Brain Tumor;   High Grade Glioma
Interventions: Drug: topotecan;   Device: Cleveland Multiport Catheter
35 Recruiting Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Recurrent Glioblastoma
Conditions: Glioma;   Glioblastoma;   Glioblastoma Multiforme;   GBM;   Brain Cancer
Intervention: Drug: VAL-083, Dianhydrogalactitol
36 Recruiting Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Condition: Chronic Ischemic Stroke
Interventions: Biological: SB623 Implant (2.5M);   Biological: SB623 Implant (5.0M);   Procedure: Sham surgery
37 Recruiting Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS)
Condition: Stroke
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Aspirin (Acetylsalicylic acid, BAY1019036);   Other: Rivaroxaban-Placebo;   Other: Aspirin-Placebo
38 Recruiting Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy
Condition: Epilepsy
Intervention: Drug: perampanel
39 Recruiting A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With Epilepsy
Condition: Epilepsy
Interventions: Drug: Topiramate;   Drug: Levetiracetam
40 Recruiting A Multicenter, Open-Label Proof-of-Concept Trial of Ganaxolone in Children With PCDH19 Female Pediatric Epilepsy and Other Rare Genetic Epilepsies
Condition: Epilepsy
Intervention: Drug: Ganaxolone

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.